ARTV – artiva biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Form 4 Artiva Biotherapeutics, For: Sep 12 Filed by: Horan Christopher
Form 4 Artiva Biotherapeutics, For: Sep 12 Filed by: Raymon Heather
Form 4 Artiva Biotherapeutics, For: Sep 12 Filed by: Graef Thorsten
Form 4 Artiva Biotherapeutics, For: Sep 12 Filed by: Bush Jennifer
Form 4 Artiva Biotherapeutics, For: Sep 12 Filed by: Krishnamohan Neha
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.